Ftse Mib
33.707,21
0,00%
DAX
18.162,53
0,00%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.586,58
-0,36%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeoVax Labs Inc (GOVX) GeoVax Labs Inc (GOVX) Notizie

GOVX

GeoVax Labs (GOVX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GOVX
DataOraFonteTitoloSimboloCompagnia
04/04/202418:30GlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXGeoVax Labs Inc
28/03/202414:00GlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
12/03/202414:00GlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXGeoVax Labs Inc
11/03/202421:13Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:GOVXGeoVax Labs Inc
11/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
06/03/202415:00GlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXGeoVax Labs Inc
01/03/202422:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
29/02/202422:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOVXGeoVax Labs Inc
29/02/202422:00GlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXGeoVax Labs Inc
22/02/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
22/02/202415:00GlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXGeoVax Labs Inc
19/02/202415:00GlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXGeoVax Labs Inc
16/02/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
14/02/202421:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GOVXGeoVax Labs Inc
13/02/202415:00GlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXGeoVax Labs Inc
06/02/202415:00GlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXGeoVax Labs Inc
29/01/202415:00GlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXGeoVax Labs Inc
12/01/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXGeoVax Labs Inc
08/01/202415:00GlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXGeoVax Labs Inc
04/01/202415:00GlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXGeoVax Labs Inc
03/01/202415:00GlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXGeoVax Labs Inc
02/01/202422:10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
27/12/202315:00GlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXGeoVax Labs Inc
19/12/202315:00GlobeNewswire Inc.GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxNASDAQ:GOVXGeoVax Labs Inc
30/11/202322:30GlobeNewswire Inc.GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
29/11/202315:00GlobeNewswire Inc.GeoVax to Participate in Upcoming December Investor EventsNASDAQ:GOVXGeoVax Labs Inc
28/11/202315:00GlobeNewswire Inc.GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
27/11/202322:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GOVXGeoVax Labs Inc
17/11/202322:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GOVXGeoVax Labs Inc
14/11/202315:00GlobeNewswire Inc.Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023NASDAQ:GOVXGeoVax Labs Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GOVX

La tua Cronologia

USOTC
BDRFF
Beiersdorf (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network